DrugAgent: Explainable Drug Repurposing Agent with Large Language Model-based Reasoning

Yoshitaka Inoue,Tianci Song,Tianfan Fu
2024-09-17
Abstract:Drug repurposing offers a promising avenue for accelerating drug development by identifying new therapeutic potentials of existing drugs. In this paper, we propose a multi-agent framework to enhance the drug repurposing process using state-of-the-art machine learning techniques and knowledge integration. Our framework comprises several specialized agents: an AI Agent trains robust drug-target interaction (DTI) models; a Knowledge Graph Agent utilizes the drug-gene interaction database (DGIdb), DrugBank, Comparative Toxicogenomics Database (CTD), and Search Tool for Interactions of Chemicals (STITCH) to systematically extract DTIs; and a Search Agent interacts with biomedical literature to annotate and verify computational predictions. By integrating outputs from these agents, our system effectively harnesses diverse data sources, including external databases, to propose viable repurposing candidates. Preliminary results demonstrate the potential of our approach in not only predicting drug-disease interactions but also in reducing the time and cost associated with traditional drug discovery methods. This paper highlights the scalability of multi-agent systems in biomedical research and their role in driving innovation in drug repurposing. Our approach not only outperforms existing methods in predicting drug repurposing potential but also provides interpretable results, paving the way for more efficient and cost-effective drug discovery processes.
Artificial Intelligence,Computation and Language,Information Retrieval,Machine Learning,Quantitative Methods
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the challenges in drug repurposing. Specifically, the paper proposes a multi - agent framework, aiming to enhance the drug repurposing process by leveraging state - of - the - art machine - learning techniques and integrating diverse knowledge sources. This framework consists of three specialized agents: 1. **AI Agent**: Develop robust drug - target interaction (DTI) models. 2. **Knowledge Graph Agent**: Extract DTI information from established databases such as DGIdb, DrugBank, CTD and STITCH. 3. **Search Agent**: Interact with biomedical literature, label and validate computational predictions. By synthesizing the outputs of these agents, the system can utilize a wide range of data sources to propose viable drug repurposing candidates. Preliminary results show that this framework can not only predict drug - disease interactions, but also reduce the time and cost required by traditional drug discovery methods. In addition, this method outperforms existing methods in predicting the potential for drug repurposing and provides interpretable results. Overall, the main goal of this paper is to improve the efficiency and accuracy of drug repurposing through a multi - agent system, thereby accelerating the drug discovery process.